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Neonatal Risk in Children of Women With Congenital Heart Disease:
A Cohort Study With Focus on Socioeconomic Status
Stine Kloster, Msc; Janne S. Tolstrup, PhD, DMSci; Morten Smærup Olsen, MD, PhD; Søren Paaske Johnsen, MD, PhD;
Lars Søndergaard, MD, DMSc; Dorte Guldbrand Nielsen, MD, PhD; Annette Kjær Ersbøll, PhD
Background-—We hypothesized that women with congenital heart disease (CHD) are at increased risk of giving birth preterm,
including very and moderately preterm and giving birth to infants small for gestational age (SGA). We aimed to investigate this in a
nation-wide study with focus on the potential modifying effect of socioeconomic status.
Methods and Results-—We performed a cohort study using Danish nation-wide registers between 1997 and 2014. The exposure,
maternal CHD, was subdivided into simple, moderate and complex based on severity of defects. Outcomes were preterm birth and
SGA. Cox regression was used to estimate hazard ratios (HR). A total of 933 149 births including 3745 births among women with
CHD were studied. The risk of giving birth preterm and SGA were higher among women with CHD as compared with women
without CHD; for example, adjusted hazard ratios of preterm birth according to severity: simple 1.33 (95% CI, 1.11–1.59),
moderate 1.45 (95% CI, 1.14–1.83) and complex 3.26 (95% CI, 2.41–4.40). Same pattern was seen for very and moderately
preterm births and SGA. Education was a strong predictor of both preterm birth and SGA but did not modify the association
between maternal congenital heart disease and preterm birth (P=0.38) or SGA (P=0.99).
Conclusions-—Women with CHD were at increased risk of preterm birth both, moderately and very preterm, as well as giving birth
to infants SGA. Education was a strong predictor of both preterm birth and SGA but the association between CHD and risk of
preterm birth and SGA was independent of educational level. ( J Am Heart Assoc. 2019;8:e013491. DOI: 10.1161/JAHA.119.
013491.)
Key Words: congenital heart disease • pregnancy • preterm birth • small for gestational age • socioeconomic position
B ecause of advances in diagnosis and treatment, morewomen with congenital heart disease (CHD) are reaching
childbearing age compared with earlier.1,2 Some CHDs
increase risk of obstetric and cardiac complications during
pregnancy and childbirth.3–11 Likewise, studies indicate an
increased risk of adverse neonatal outcomes such as
premature birth and small for gestational age (SGA),3,9,12–15
which are predictors of neonatal morbidity and mortality,16,17
and morbidity in adult life.18 The adverse effect of being born
preterm is associated with the degree of prematurity.
However, the association between maternal CHD and preterm
birth primarily focus on preterm birth, and only a few studies
examine degree of prematurity.19,20 These studies are limited
by the small sample sizes and selected study populations.
Hence, evidence of the risk of very premature birth in the
general population of women with CHD is still lacking.
Preterm birth and giving birth to an SGA infant in general
occur more commonly among disadvantaged socioeconomic
groups,21 thereby contributing to inequalities in health.
However, whether this inequality also exists among women
with CHD is unknown. A study showed no association
between countries with different Human Development Index
and the rate of SGA among women with CHD; however,
individual socioeconomic status was not accounted for.22
We hypothesized that women with CHD, who have entered
22 completed weeks of pregnancy (ie, gestational age is
154 days), are at increased risk of giving birth preterm,
including very (22–31 completed weeks) and moderately (32–
36 completed weeks) preterm and giving birth to SGA infants.
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We aimed to investigate this in a nation-wide study with
particular focus on the potential modifying effect of socioe-
conomic status at an individual level.
Methods
Study Design
In Denmark, all citizens have free access to health care and
are assigned a unique identification number, which enables
individual-level linkage across national registers.23 The study
was a national cohort study with prospectively collected data
from the Danish Medical Birth Register24,25 and the Danish
National Patient Register.26 Data will not be made available to
other researchers for the purpose of reproducing the results
because this would be a violation of the Danish General Data
Protection Regulation and data Privacy Regulation by Statistic
Denmark.
Study Population
All births registered in the Danish Medical Birth Register
between 1997 and 2014 constituted the study population. All
singleton births among women born in Denmark were
included (n=952 882). The register holds information on all
live and stillbirths, including information of both mother and
child related to the pregnancy and delivery.24,25 Women were
included in the cohort at day 154 of gestation (22 completed
weeks) and followed until birth.
Maternal Congenital Heart Disease
Information about maternal CHD was obtained from the
Danish National Patient Register, which is a population-based
administrative register holding information on all hospital
admissions since 1977.26 All women with a diagnosis of CHD
(International Classification of Diseases, Tenth Revision [ICD-
10]; Q20–Q26, International Classification of Diseases, Eighth
Revision [ICD-8]; 746–747) between 1977 and 2016 were
included except ICD-10 Q26.5 to Q26.6 and ICD-8 746.7 and
747.5 to 747.9, which are not specific for CHD. To increase
the positive predictive value of the diagnosis of CHD, we
excluded individuals with, for example, unspecific diagnoses
using an algorithm previously described.27 For example,
diagnosis of ASD was excluded if given at ages <2 months
without an associated operation code; diagnosis of congenital
stenosis of aortic valve was excluded if given at ages
>40 years, etc (see appendix in Olsen et al for more
details27). Based on guidelines from the European Society of
Cardiology, CHD was categorized into no, simple, moderate,
and complex.28 Women with >1 diagnosis were categorized
according to the more-severe diagnosis. We included women
diagnosed before, during, and after pregnancy under the
hypothesis that underlying CHD affected the pregnancy and
its outcome irrespective of whether the disease was diag-
nosed at the time of delivery.
Outcomes
Information on preterm birth and SGA was obtained from the
Danish Medical Birth Register.24,25 During the study period,
gestational age was primarily determined based on ultra-
sonography. Preterm birth was defined as birth between 22
and 36 weeks of completed gestation (154–258 days).
Preterm birth was further categorized into very preterm
(22–31 completed weeks) and moderately preterm (32–36
completed weeks).29,30 Births with implausible birthweights
according to gestational age were excluded.31 SGA was
defined as birthweight falling below the 10th percentile of
birthweight according to standard references32 and calculated
for males and females, separately.
Covariates
Ethnicity, maternal age, parity, educational level, and calendar
year were identified as confounders a priori using Directed
Acyclic Graphs (available from the authors).33 Information
about ethnicity was obtained from the Danish Civil Registra-
tion System and grouped into Europeans/North Americans,
Clinical Perspective
What Is New?
• We showed that the risk of preterm birth, both moderately
and very preterm, was higher among women with congenital
heart disease in an unselected population.
• Socioeconomic status was a strong predictor of preterm
birth and small for gestational age also among women with
congenital heart disease, however, the association between
congenital heart disease and risk of preterm birth and small
for gestational age apparently seemed to be independent of
socioeconomic status in a population with free and equal
access to health care.
What Are the Clinical Implications?
• In particular, the increased risk of very preterm birth may
potentially be used during counselling regarding risk in
pregnancy among women with a congenital heart disease.
• The difference in risk between different socioeconomic
groups for both preterm birth and small for gestational age
in a country with free and equal access to health care need
awareness and mechanisms behind this inequality among
women with congenital heart disease need to be addressed.
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Asians, and Africans/others. This was done because CHD is
more prevalent among Asians and Europeans34 and preterm
birth is more prevalent among Africans.35 Maternal age and
calendar year were assessed at inclusion. Age was catego-
rized into: <20, 20 to 24, 25 to 29, 30 to 34, and ≥35 years.
Year of inclusion was grouped into 5-year bands, except the
last interval which contained 4 years. Information about parity
was obtained from the Danish Medical Birth Register and
grouped into nulli-, primi-, and multiparous. Parity was
corrected based on the available information in the Danish
Medical Birth Register (Data S1).
Socioeconomic status was assessed by educational level,
which has shown to be a strong socioeconomic predictor of
the risk of both preterm birth and SGA in Denmark.29
Information about the highest level of completed education
October 1 the year preceding each birth was obtained from
the Danish Education Register.36 Education was classified
according to the International Standard Classification of
Education System (ISCED 2011)37 and categorized into 3
groups: low education (preprimary, primary, and lower
secondary; ISCED level 1–2); medium (upper secondary and
postsecondary; ISCED level 3–4); and high (tertiary education
ISCED level 5–8).
For descriptive purposes information on smoking, prepreg-
nancy body mass index, number of hospital contacts 1 year
before start of the index pregnancy, stillbirths, and induction
was included.
Statistical Analysis
For the descriptive analyses, median and interquartile range
was used for continuous variables, and counts with propor-
tions was used for categorical variables.
A Cox proportional hazard model was used to investigate
the association between maternal CHD and preterm birth and
SGA. Gestational age in days was used as the underlying time
scale. Women entered the cohort at day 154 of gestation. For
preterm birth, the follow-up time was terminated at birth or
after 258 days of gestation, whichever came first. Pregnancies
ending with stillbirth were censored at the time of stillbirth or
after 258 days. When analyzing the risk of very preterm birth,
the follow-up time was terminated at birth or after 223 days
(cut point for very preterm birth, <32 completed weeks), and
all ongoing pregnancies were censored. When analyzing the
risk of moderately preterm birth, all pregnancies not ending in
a very preterm birth were included and follow-up time was
terminated at birth or after 258 days. When analyzing the
association with SGA, the pregnancies were followed until
birth. Adjustment was made for maternal age, calendar year,
ethnicity, parity, and educational level. Some women con-
tributed with >1 birth to the cohort. To account for the
clustered structure of the data, a cluster-robust standard error
estimator was used. Results were presented as hazard ratios
(HRs) with 95% CIs. The overall effect of CHD and educational
level was derived using Wald’s test.
The possible effect modification of educational level on
the association between CHD and the outcomes was tested
on a multiplicative scale by including the main effects and
the interaction term in the fully adjusted model. Wald’s test
was used to test whether the interaction was significant. The
joint effect was examined by combining CHD and educational
level into a single variable with 12 categories with a common
reference group (women with high education without CHD).
Differences in HRs between complex CHD and no CHD were
compared at the different educational levels using Wald’s
test: low versus medium, low versus high, and medium
versus high. Likewise, this was done for simple and moderate
CHD.
The proportional hazard assumption was evaluated visually
using log-log plots.
Births with missing information on gestational age and
birthweight were excluded.
Sensitivity Analysis
The assumption of proportional hazards was violated for the
age category <20 years for preterm birth. To examine
whether this affected the estimates of the main exposure
(CHD), all analyses were conducted in strata of age and by
including an interaction term between age and gestational
age. To further examine the potential influence of nonpropor-
tional hazards, all analyses were also conducted using a
Poisson regression of incidence rates.
Several sensitivity analyses were conducted. First, the risk
of preterm birth was modeled with stillbirth as a competing
risk. Second, analyses of preterm birth and SGA were
restricted to women diagnosed with CHD before delivery to
examine the effect of knowing the disease beforehand. Third,
the analysis was restricted to nulliparous women in order to
eliminate the effect of any similar previous pregnancy
outcome (eg, preterm birth). Fourth, induced births were
modeled as a competing risk to spontaneous preterm births.
Last, an analysis was conducted where SGA was defined as
birthweight below 2 SDs of the mean birthweight according to
standard references32 and calculated for males and females,
separately. This was done because both <10th percentile and
2 SDs below the mean are used in the literature. The
definition with 2 SDs only captures the most extreme SGA
infants.
Data management done in order to derive the CHD
cohort was done using SAS software (version 9.4; SAS
Institute Inc, Cary, NC. All analyses were performed using
Stata/IC software (version 15.0; StataCorp LP, College
Station, TX).
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Ethical Considerations
The study was approved by the Danish Data Protection
Agency (2015-57-0008, no. 16/48885). In Denmark, written
informed consent or ethical approval is not required for
register-based studies. All data were provided by Statistics
Denmark, and because of their data privacy regulation, data
with <5 individuals per cell were not reported.
Results
Participants
We identified 952 882 singleton births in the study period. Of
these, 218 births were excluded because pregnancy ended
before 22 (n=159) or after 44 (n=59) weeks of completed
gestation, 577 births because of implausible birthweights, and
18 938 (2%) births because of missing information on
gestational age resulting in a study population of 933 149
births among 548 714 women (Figure 1). Birthweight was
missing for another 7024 (0.75%) births, and the analysis
sample for SGA therefore consisted of 926 125 births among
546 903 women. A total of 3745 births were among 2212
women with CHD.
Maternal and Birth Characteristics
The most common CHDs were the simple defects, atrial
septal defect and ventricular septal defect. Within complex
CHDs, transposition of the great arteries constituted the
majority of diagnosis. The distribution of each CHD, stratified
by complexity, is reported in Table S1. Compared with women
without CHD, women with CHD were slightly younger, less
educated, and more were nulliparous (Table). Furthermore,
there were a larger proportion of stillbirths and inductions
among women with CHD, and they had, on average, more
hospital contacts the year before pregnancy as compared
with women without CHD.
The overall proportion of preterm birth was 5.0% (n=46 601)
and SGA 10.5% (n=96 802). The median gestational age was
280 days (interquartile range, 273–287). Median follow-up
time (ie, time from 154 days of gestation to censoring or birth)
was 105 days (range, 1–105) in the analysis of preterm births
and 127 days (range, 1–161) in the analysis of SGA.
Main Results
Women with CHD had a higher risk of any preterm birth as
compared with women without CHD (Figure 2A). The risk of
preterm birth increased with increasing severity of thematernal
CHD, with an HR of 1.33 (95% CI, 1.11–1.59) for simple, 1.45
(95% CI,1.14–1.83) for moderate, and 3.26 (95% CI, 2.41–4.40)
for complex defects. The same pattern was found when
analyzing subgroups of preterm birth with even higher HR of
very preterm birth with an HR at 1.62 (95% CI, 1.09–2.39) for
simple, 1.37 (95% CI, 0.70–2.70) for moderate, and 5.02 (95%
CI, 2.84–8.90) for complex defects. Adjustment for con-
founders did not affect the HRs substantially, for example, 3%
for any preterm birth (crude estimates in Table S2).
Likewise, the risk of giving birth to an infant born SGA was
higher among women with CHD as compared with women
without. As for preterm birth, the risk increased with
increasing severity of the heart disease; adjusted HRs of
simple 1.27 (95% CI, 1.11–1.45), moderate 1.56 (95% CI,
1.29–1.87), and complex 2.32 (95% CI, 1.69–3.18) defects.
A lower educational level was strongly associated with
higher risk of any preterm birth (Figure 2B). The adjusted HRs
of low and medium education as compared with high
education was 1.76 (95% CI, 1.71–1.82) and 1.25 (95% CI,
1.22–1.28), respectively. The association between maternal
CHD and any preterm birth was independent of educational
level (P value for interaction=0.38). HRs of preterm birth and
SGA within strata of education are given in Figure 3.
Differences in HR between each group of CHD and women
without were similar between educational levels. The only
exception was among women with a complex CHD, where
differences in HR were significantly higher for women with a
low education as compared with women with a medium
education (Figure 3).
Likewise, education was strongly associated with SGA
(Figure 2B). The adjusted HRs of low and medium education
as compared with high education was 1.96 (95% CI, 1.92–
2.00) and 1.26 (95% CI, 1.24–1.28), respectively. As for
preterm births, the association between CHD and SGA was
independent of educational level (P value for interac-
tion=0.99). Differences in HR among women with CHD and
women without were similar at all educational levels.
Sensitivity Analyses
Cox regressions conducted in strata of age or by including an
interaction term between age and gestational age showed
that HRs for simple, moderate, and complex defects were
essentially the same. Likewise, estimates of CHD were
similar when analyses were run as Poisson regression of
incidence rates. However, for very preterm birth, the analysis
did not converge.
Modelling stillbirth as a competing risk to preterm birth
essentially gave the same estimates (Table S3). Restricting
the analysis to women diagnosed with CHD before the index
pregnancy showed the same pattern, but resulted in slightly
higher adjusted HR, for example, simple 1.39 (95% CI, 1.14–
1.69) and complex 3.40 (95% CI, 2.49–4.65) for preterm birth
(Table S4). Restricting the analysis to nulliparous women
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resulted in the same pattern as for the full cohort (Table S5).
However, the differences for simple and moderate were only
borderline significant.
Modeling induced births as a competing risk to sponta-
neous preterm birth, the pattern and size of estimates were
almost similar (Table S6).
n=997,332 
births
n= 997,322
births
Dublets
n=10
Validated maternal 
diagnosis of 
congenital heart 
disease
n=3,745 births 
among 2,212 
women
Mulple 
pregnancies
n=44,440
n= 952,882
births
Educaon
Implausible 
birthweights
n=577
n= 952,664
births
n= 952,087
births
Births before 22 
completed weeks 
(before 154 days)
n=159 aer 44 
completed weeks 
>314 days) n=59
Danish Medical 
Birth Register (MBR)
n=1,152,963 Mother not born in
Denmark
n=155,595
Missing informaon
n=36
Ethnicity
Analysis sample 
preterm birth:
n=933,149
Study inclusion
Missing data:
Gestaonal age: 
n=18,938
Analysis sample 
SGA:
n=926,125
Missing data:
Birthweight
n=7,024
Figure 1. Flow diagram of data from the Danish Medical Birth Register.
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When defining SGA as infants falling below 2 SDs of the
mean birthweight, the same pattern was noted. However, the
HR of SGA was higher for complex CHD when the definition of
2 SDs was used (Table S7).
Discussion
We found that womenwithCHDhad a higher risk of preterm birth,
bothmoderately and very preterm, andSGA.Furthermore, the risk
Table. Baseline Characteristics by Congenital Disease Status in 548 714 Women and 933 149 Births
Maternal Congenital Heart Disease
No (n=929 462) Simple (n=2224) Moderate (n=1082) Complex (n=381)
N (%) N (%) N (%) N (%)
929 462 2224 1082 381
Age, y
Median (IQR) 30.1 (26.9–33.4) 29.3 (25.6–32.6) 29.5 (26.4–32.8) 29.0 (25.7–32.4)
<20 1.8 3.8 2.9 2.4
20 to 24 12.3 18.1 14.0 19.4
25 to 29 35.2 34.2 38.3 34.9
30 to 34 34.9 31.6 31.9 32.8
≥35 15.8 12.3 12.9 10.5
Ethnicity 929 455 2224 1082 381
Europeans/North Americans 99.4 98.5 99.7 98.2
Asians 0.5 <30* NA† <5* NA† <5* NA†
Africans/others 0.1 <30* NA† <5* NA† <5* NA†
Parity 917 499 2198 1069 380
Nulliparous 43.8 48.4 48.4 45.3
Primiparous 38.7 36.3 37.0 35.0
Multiparous 17.5 15.3 14.6 19.7
Education 917 427 2219 1067 372
Low 19.1 27.1 22.6 27.2
Medium 43.7 40.3 41.4 46.8
High 37.2 32.6 36.0 26.1
Smoking 845 078 2068 972 341
Yes 17.6 19.7 15.4 17.3
Prepregnancy BMI 531 049 1462 682 246
Underweight (<18.5) 4.1 4.9 5.7 5.7
Normal (18.5–<25) 62.4 62.3 62.2 65.8
Overweight (≥25) 33.5 32.8 32.1 28.5
No. of hospital contacts 1 year
before start of pregnancy‡
929 462 2224 1082 381
Median (IQR) 0 (0–1) 0 (0–1) 0 (0–1) 0 (0–2)
MeanSD 0.631.35 0.911.65 0.881.63 1.051.75
Stillbirth 2942 0.3 16 0.7 9 0.8 6 1.6
Induction overall 136 845 14.7 401 18.0 196 18.1 72 18.9
Induction among preterm births 5533 12.0 15 10.0 13 16.7 <5* NA†
N indicates number of births; BMI indicates body mass index; IQR, interquartile range; NA, not applicable.
*Exact n is not given because of data privacy policy. The exact number is known by the researchers and used in calculations.
†
Not applicable because of low n.
‡
Number of contacts the year before the start of the index pregnancy. Contacts with primary reason of congenital heart disease or pregnancy were excluded.
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of both outcomes increased with severity of the CHD. Socioeco-
nomic status, as determined by maternal educational level, was a
strong predictor of preterm birth and SGA. The association
betweenCHDand risk of pretermbirth andSGAapparently seems
to be independent of educational level; however, this could be
attributable to low power because of few events.
Our results add to the literature showing that maternal
CHD is associated with preterm birth and SGA.3,9,12–15
Although some studies found no association between
preterm birth or SGA and CHD,8,38 this may be attributable
to small sample sizes. By including the total population of
pregnant women with and without CHD in Denmark during
A N births/N events Maternal 
congenital 
heart disease
Adjusted
HR (95%CI)
Overall 
p-value
<0.001
Any preterm birth 
(22-36 completed weeks)
905,638/44,945 No 1 (reference)
2,166/147 Simple 1.33 (1.11-1.59)
1,054/76 Moderate 1.45 (1.14-1.83)
371/57 Complex 3.26 (2.41-4.40)
<0.001
Very preterm
(22-31 completed weeks)
905,6386,168 No 1 (reference)
2,166/25 Simple 1.62 (1.09-2.39)
1,054/10 Moderate 1.37 (0.70-2.70)*
371/13 Complex 5.02 (2.84-8.90)
<0.001
Moderately preterm
(32-36 completed weeks)
899,47038,777 No 1 (reference)
2,141/122 Simple 1.28 (1.06-1.55)
1,044/66 Moderate 1.46 (1.14-1.87)
358/44 Complex 2.95 (2.12-4.12)
<0.001
Small for gestaonal age
899,187/93,309 No 1 (reference)
2,142/282 Simple 1.27 (1.11-1.45)
1,040/144 Moderate 1.56 (1.29-1.87)
363/63 Complex 2.32 (1.69-3.18)
B N births/N events Educaonal 
level
Adjusted
HR (95%CI)
Overall 
p-value
<0.001
Any preterm birth 
(22-36 completed weeks)
173,011/11,252 Low 1.76 (1.71-1.82)
397,197/19,832 Medium 1.25 (1.22-1.28)
339,021/14,141 High 1 (reference)
<0.001
Very preterm
(22-31 completed weeks)
173,011/1,726 Low 2.21 (2.05-2.38)
397,197/2,628 Medium 1.33 (1.24-1.41)
339,021/1,862 High 1 (reference)
<0.001
Moderately preterm
(32-36 completed weeks)
171,285/9,526 Low 1.70 (1.64-1.75)
394,569/17,204 Medium 1.24 (1.21-1.27)
337,159/12,279 High 1 (reference)
<0.001
Small for gestaonal age
171,518/24,480 Low 1.96 (1.92-2.00)
394,446/40,085 Medium 1.26 (1.24-1.28)
336,768/29,233 High 1 (reference)
Figure 2. A, Hazard ratios (HRs) of the association between severity of maternal congenital heart disease and preterm birth and small for
gestational age. HRs are adjusted for maternal age and calendar year at inclusion, ethnicity, parity, and level of education. Women without
congenital heart disease are used as a reference. *Not significantly different from simple congenital heart disease. B, HRs of the association
between educational level and preterm birth and small for gestational age. HRs are adjusted for congenital heart disease, maternal age, and
calendar year at inclusion, ethnicity, and parity. Women with a high level of education are used as a reference.
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18 years, we obtained a large sample size to estimate the
association between CHD and preterm birth and SGA,
thereby contributing with solid evidence from a nation-wide
register in a country with universal and free healthcare
coverage.
Our estimates are similar to the findings of Hayward et al,
who report an odds ratio of 1.6 for noncomplex and 3.0 for
complex CHD.13 The definition of severity differs because they
categorized CHD into complex and noncomplex; however, the
definition of complex CHD is similar with the primary
exception of tetralogy of Fallot, which, in our study, is
categorized as a moderate defect. Thompson et al5 evaluated
women with CHD as 1 group and found an odds ratio of 1.66.
This is a lower estimate compared with ours when considered
that women with complex CHD are included in the estimate.
In both studies, the researchers adjusted for comorbidities
that might be mediators of the association between CHD and
preterm birth.
To our knowledge, the degree of prematurity has not
previously been determined in the general population of
women with CHD. Only a few small studies report event
frequencies of degree of prematurity.19,20 We report a higher
risk of both very preterm and moderately preterm births
among women with CHD.
Births among women with CHD are more often
induced20,39 which is also the case in our study. However,
among preterm births, there was no difference in frequency of
induction among women with CHD and women without (data
not shown). Furthermore, when induction was modeled as a
competing risk to spontaneous preterm births, the results
were similar as in the main analysis, indicating that the
association is not attributable to difference in induction
among women with and without CHD.
Our results add to the evidence that maternal CHD
predisposes to a lower fetal growth rate. As recently shown,
women with CHD have smaller babies compared with healthy
HR of preterm birth and SGA by maternal congenital heart disease
Educaon N births/N events Maternal 
congenital 
heart disease
Combined effect of congenital heart disease and 
educaon. Comparison is made to women with high 
educaon without congenital heart disease.
Within strata of educaonal level. Comparison is made to 
women without congenital heart disease. 
HR* (95%CI) HR* (95%CI)
Pr
et
er
m
 b
irt
h
Low 172,086/11,161 No 1.76 (1.71-1.82) 1 (reference)
585/43 Simple 2.00 (1.44-2.78) 1.14 (0.82-1.58)
239/22 Moderate 2.56 (1.69-3.89) 1.46 (0.96-2.21)
101/26 Complex 8.30 (5.19-13.26)  4.71 (2.95-7.52)
Medium 395,712/19,718 No 1.25 (1.22-1.28) 1 (reference)
878/65 Simple 1.87 (1.42-2.45) 1.49 (1.13-1.95)
434/30 Moderate 1.74 (1.18-2.56) 1.38 (0.94-2.04)
173/19 Complex 2.89 (1.83-4.54) 2.30 (1.46-3.62)
High 337,840/14,066 No 1 (reference) 1(reference)
703/39 Simple 1.34 (0.97-1.85) 1.34 (0.97-1.85)
381/24 Moderate 1.52 (0.99-2.33) 1.52 (0.99-2.33)
97/12 Complex 3.23 (1.63-6.37) 3.23 (1.63-6.37)
Sm
al
lf
or
 g
es
ta
o
na
l a
ge
Low 170,606/7,181 No 1.96 (1.92-2.00) 1 (reference)
575/25 Simple 2.46 (1.93-3.14) 1.26 (0.98-1.60)
236/15 Moderate 2.84 (1.99-4.07) 1.45 (1.01-2.08)
101/7 Complex 4.58 (2.75-7.64) 2.34 (1.40-3.90)
Medium 392,981/10,220 No 1.26 (1.24-1.28) 1 (reference)
872/29 Simple 1.67 (1.37-2.05) 1.33 (1.09-1.63)
425/14 Moderate 2.09 (1.58-2.77) 1.67 (1.26-2.20)
168/15 Complex 2.87 (1.84-4.50) 2.29 (1.46-3.58)
High 335,600/6,641 No 1 (reference) 1 (reference)
695/18 Simple 1.20 (0.94-1.55) 1.20 (0.94-1.55)
379/11 Moderate 1.53 (1.11-2.09) 1.53 (1.11-2.09)
94/6 Complex 2.33 (1.12-4.89) 2.33 (1.12-4.89)
Figure 3. To the left, hazard ratios (HRs) of preterm birth (upper) and small for gestational age (SGA; lower) for the joint effect of educational
level and maternal congenital heart disease are given. To the right, HRs of preterm birth (upper) and SGA (lower) by maternal congenital heart
disease within strata of educational level are given. *Adjusted for maternal age and calendar year at inclusion, ethnicity, and parity. †Differences
in HR between women without congenital heart disease and women with a complex congenital heart disease were significantly higher for
women with a low education as compared with women with a medium education (P=0.03). P value of interaction; preterm birth, P=0.38; SGA,
P=0.99.
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women.12 Similar findings have been reported by
others.5,8,15,19 However, the size of effect differs between
studies and might partly be explained by differences in the
definition of SGA. When SGA was defined as infants falling
below 2 SDs of the mean birthweight, we found the same
pattern. However, the HR of SGA was higher among women
with a complex CHD. Given that defining SGA as falling below
2 SDs of the mean birthweight only captures the most
extreme SGA infants, this might indicate that women with a
complex CHD tend to give birth to smaller infants and this
effect is then attenuated when the definition of SGA is
broader. Regardless of the definition of SGA, the restriction in
fetal growth among women with CHD could be attributable to
a reduced cardiac output that causes a disturbed uteropla-
cental blood flow.40,41
Influence of Socioeconomic Status
Little is known about if and how socioeconomic status affects
birth outcome among women with CHD. Our results indicate
that inequality in adverse birth outcomes does exist among
women with CHD even in a country with free and equal access
to health care. The educationally patterned risk of preterm
birth and SGA is worrying because this might be the first sign
of health inequality in health in later life.21 This might be even
more pronounced among children of women with CHD given
that more of these children will have CHD and other
malformations themselves,15 which are also known to cluster
in more socially disadvantaged groups,21 thereby placing
children of women with CHD as a particularly vulnerable group
with higher concentration of risk factors for inequality in
health in later life. Children with CHD will furthermore tend to
achieve a lower educational level,42 and thereby social
inequality is passed across generations. Additionally, it has
been well documented that the inequality in health does exist
in the risk of disease, as shown in this study, but also in the
consequence of disease.43
Research and Clinical Implications
We showed a 5-fold increased risk of very preterm birth
among women with a complex CHD. Therefore, the risk of
preterm birth is not just a question of giving birth close to
term. This is of clinical importance given that the adverse
effects of being born preterm differ by degree of prematurity.
This information might be used in future counseling regarding
risk in pregnancy among women with CHD. Furthermore,
children born to women with CHD will be at increased risk of
being born SGA, making these children even more vulnerable.
In Denmark, all citizens have free and equal access to
health care; however, we found a socioeconomic patterned
risk of preterm birth and SGA. The mechanism behind this
association is complex and not completely understood,44 but
might partly be explained by differences in health behavior
and differences in the experience of social advantages or
disadvantages across the life course.45 However, the mech-
anisms behind this might differ for women with and without
CHD and need further investigation.
Factors such as preeclampsia and gestational hypertension
might be important to consider when predicting the risk of
preterm birth and SGA among women with CHD. However, we
consider these conditions as mediators on the causal path
from maternal CHD to preterm birth or SGA. Therefore, these
conditions were not included in the statistical analysis.46
Higher prevalence of preeclampsia/eclampsia or other ges-
tational hypertensive disorders have been reported among
women with heart disease.9,13 To investigate the mediating
factors between CHD and adverse perinatal outcomes was
beyond the scope of this article. However, in order to reduce
adverse neonatal outcomes among women with CHD, future
studies should focus on the mediating factors between CHD
and adverse neonatal outcomes. Neonatal complications tend
to follow a pattern similar to maternal and obstetric outcomes
among women with heart disease in general,9 indicating that
the association between CHD and these different outcomes
might be mediated through shared factors.
Strengths and Limitations
Inclusion of all women diagnosed with a CHD in Denmark, as
opposed to including from specialized clinics, limits the risk of
selection bias. Additionally, this increases power to analyze
subgroups of preterm births. Given that data are based on a
nation-wide sample, we were able to include women with simple
CHD,whoconstitute thebiggest part ofwomenwithCHDand, as
shown in this study, also have a higher risk of preterm birth and
SGA than women without CHD. Furthermore, this improves the
ability to transfer the results to a real-world setting.
When analyses were restricted to nulliparous women
findings were similar, which strengthen the main findings in
the study, ruling out that risks are attributable to previous
similar birth outcomes such as preterm birth.
A further strength of our study is the validation of CHD
diagnosis. As recently described, the use of diagnosis of CHD
from administrative databases is associated with some
inaccuracy.47 In general, diagnosis of CHD has a high positive
predictive value in the Danish National Patient Register,48,49
and to further increase the validity of the included diagnoses,
we used an algorithm previously described27 to exclude
invalid diagnosis of CHD or inaccurate coding in the Danish
National Patient Register.
The Danish universal healthcare system with free and
equitable access to care regardless of economic resources
offers unique possibilities for studying the socioeconomic
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gradient in risk of preterm birth and SGA among women
with CHD. We were able to include information about
socioeconomic status at an individual level, which, to our
knowledge, has not previously been done among women
with CHD.
A drawback of the study is the inability to account for the
variability in severity within both the CHD category, but also
within a given diagnosis of CHD.
In conclusion, our study showed that women with CHD
were at increased risk of preterm birth, both moderately and
very preterm, and giving birth to an SGA infant. The risk was
higher in complex CHD. Education was a strong predictor of
both preterm birth and SGA, with higher risk among lower-
educated women. However, the association between CHD and
risk of preterm birth and SGA apparently seems to be
independent of educational level in a country with universal
healthcare coverage.
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Data S1.
Supplemental Methods 
Parity: 
Information about parity was corrected based on the available information in the Danish Medical 
Birth Register during the study period. In case a woman was noted as e.g. nulliparous and was 
registered with more than one birth during the study period, parity was corrected based on the 
available number of births in the study period. Based on the available information it was only 
possible to increase the parity of women.  Information about parity was corrected for 1.5% of the 
births. 
Maternal age: 
Maternal date of birth registered in the Danish Civil Registration System was used to calculate 
maternal age at inclusion. For women with missing information on maternal date of birth maternal 
age registered in the Danish Medical Birth Register was used (n=74). 
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Table S1. Distribution of congenital heart disease.   
Disease ICD-10 code ICD-8 code n* 
C
o
m
p
le
x/
h
ig
h
 r
is
k
 
Univentricular heart (Complex, mWHO III-IV) 
Q201, Q202, Q234, 
Q226, Q204 
154 
Eisenmenger syndrome (Complex, mWHO IV) Q218A <5
Ϯ
Pulmonary arterial hypertension (Complex, mWHO IV) Q256, Q257 74 
Pulmonary atresia (Complex, mWHO II-IV) Q255 74739 178 
Transposition of great ateries* (Complex, mWHO III) Q203 74619 286 
Truncus arteriosus (Complex, mWHO II) Q200 74609 54 
Other disconnections (ccTGA, isomerisme etc.) (Complex, mWHO III)  
Q205, Q208, Q209, 
Q241 
62 
M
o
d
er
at
e/
m
o
d
er
at
e 
ri
sk
 
Atrio-ventricular septal defect (Moderate to complex, mWHO II-III) Q212 74659, 74641 319 
Ebstein’s anomalia (Moderate to complex, mWHO II)  
Q225, Q224, Q228, 
Q229 
74661 97 
Pulmonary valve stenosis (Simple to complex, mWHO I-III) Q220, Q221 74663 321 
Tetralogy of Fallot (Moderate to complex, mWHO II) Q213 74629 439 
Partly or totally abnormal pulmonary venous connection (Complex, mWHO I)  Q262, Q263, Q242 29 
Coarctatio of the aorta (Moderate to complex, mWHO II) Q251 74719, 74729 622 
Infundibular right ventricle outflow tract obstruction (Moderate, mWHO II)  Q243 16 
Pulmonary valve regurgitate (Simple to complex, mWHO I-III) Q222 33 
Subvalvular/supravalvular aortic stenosis (Moderate, mWHO II-III) Q244, Q252, Q253 86 
Malformation of coronary vessels (ALCAPA, ARCAPA) (Moderate, mWHO II)  Q245 20 
Aortic valve disease (Simple to complex mWHO II-III) Q230, Q231 74662, 74669 598 
Mitral valve disease (Simple to complex, mWHO II-III 
Q232, Q233, Q238, 
Q239 
74660 181 
Si
m
p
le
/l
o
w
 r
is
k
 Atrial septal defect (Simple, mWHO I-II) Q211 74649, 74640 1,611 
Ventricular septal defect (Simple, mWHO I-II) 
Q210, Q214, Q218, 
Q219 
74639 2,073 
Mild pulmonary stenosis (Simple, mWHO I) Q223 9 
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Ductus arteriosus (Simple, mWHO I-II) Q250 74709 697 
Other malformations in aorta (Right aortic arch, vascular ring) (Simple, mWHO 
I) 
Q254 26 
Malformations in large veins without hemodynamic Importance (Simple, 
mWHO I) 
Q260, Q264 , Q268 30 
Other specified congenital malformations of heart Q248 74689, 74699 57 
*Women might have more than one diagnosis.
Ϯ Exact n is not given due to data privacy policy. The exact number is known by the researchers and used in calculations.  
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Table S2. Crude Hazard ratios of preterm birth and small for gestational age among women with 
congenital heart disease.  
Crude 
N events HR 95% CI Overall p-value 
Any preterm birth (22-36 completed weeks) 46,601 <0.001 
No CHD 1 
Simple 1.37 1.5-164 
Moderate 1.47 1.17-1.86 
Complex 3.39 2.52-4.55 
Very preterm (22-31 completed  weeks) 6,405 <0.001 
No CHD 1 
Simple 1.72 1.17-2.52 
Moderate 1.50 0.79-2.85* 
Complex 5.12 2.88-9.08 
Moderately preterm (32-36 completed weeks) 40,196 <0.001 
No CHD 1.32 1.09-1.59 
Simple 1.47 1.15-1.88 
Moderate 3.09 2.24-4.28 
Complex 
Small for gestational age 96,802 <0.001 
No CHD 1 
Simple 1.38 1.21-1.58 
Moderate 1.61 1.34-1.93 
Complex 2.40 1.76-3.27 
* not significantly different from simple congenital heart disease
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Table S3. Hazard ratios of preterm among women with congenital heart disease – stillbirth as 
competing risk.
Crude Adjusted* 
N events HR 95% CI Overall 
p-value 
N events HR 95% CI Overall 
p-value 
Any preterm birth 
(22-36 completed weeks) 
46,601 <0.001 45,225 <0.001 
No CHD 1 1 
Simple 1.37 1.15-1.63 1.32 1.11-1.58 
Moderate 1.47 1.16-1.85 1.44 1.14-1.82 
Complex 3.34 2.48-4.48 3.22 2.39-4.35 
Very preterm  
(22-31 completed  weeks) 
6,405 <0.001 6,216 <0.001 
No CHD 1 1 
Simple 1.71 1.17-2.51 1.61 1.09-2.38 
Moderate 1.49 0.78-2.84 1.36 0.69-2.68 
Complex 5.06 2.85-8.97 4.98 2.81-8.83 
Moderately preterm  
(32-36 completed weeks)  
40,196 <0.001 39,009 <0.001 
No CHD 1 1 
Simple 1.31 1.09-1.59 1.28 1.06-1.55 
Moderate 1.47 1.15-1.88 1.46 1.14-1.87 
Complex 3.10 2.24-4.28 2.95 2.12-4.12 
*Adjusted for maternal age and calendar year at inclusion, ethnicity, parity and level of education
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Table S4. Hazard ratio of preterm birth and small for gestational age among women diagnosed 
with congenital heart disease before delivery.
Crude Adjusted* 
N events HR 95% CI Overall 
p-value 
N events HR 95% CI Overall 
p-value 
Any preterm birth 
(22-36 completed weeks) 
46,564 <0.001 45,189 <0.001 
No CHD 1 1 
Simple 1.43 1.18-1.74 1.39 1.14-1.69 
Moderate 1.58 1.23-2.02 1.54 1.20-1.98 
Complex 3.51 2.58-4.76 3.40 2.49-4.65 
Small for gestational age 96,723 <0.001 93,722 <0.001 
No CHD 1 1 
Simple 1.39 1.20-1.61 1.26 1.08-1.46 
Moderate 1.76 1.45-2.13 1.71 1.41-2.08 
Complex 2.49 1.80-3.44 2.42 1.75-3.36 
*Adjusted for maternal age and calendar year at inclusion, ethnicity, parity and level of education
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Table S5. Hazard ratio of preterm birth restricted to nulliparous women. 
Crude Adjusted* 
N events HR 95% CI Overall 
p-value
N events HR 95% CI Overall 
p-value 
Any preterm birth 
(22-36 completed weeks) 
25,309 <0.001 24,938 <0.001 
No CHD 1 1 
Simple 1.20 0.96-1.49 1.20 0.96-1.50 
Moderate 1.35 1.00-1.82 1.35 0.99-1.82 
Complex 2.98 2.08-4.27 2.93 2.03-4.22 
Small for gestational age 55,790 <0.001 54,906 <0.001 
No CHD 1 1 
Simple 1.27 1.09-1.47 1.23 1.06-1.43 
Moderate 1.60 1.31-1.97 1.56 1.27-1.93 
Complex 2.21 1.56-3.13 2.29 1.62-3.24 
*Adjusted for maternal age and calendar year at inclusion, ethnicity, and level of education
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Table S6. Hazard ratio of spontaneous preterm birth – stillbirth and induction as competing risk. 
Crude Adjusted* 
N events HR 95% CI Overall 
p-value 
N events HR 95% CI Overall 
p-value 
Any preterm birth 
(22-36 completed weeks) 
41,036 <0.001 39,806 <0.001 
No CHD 1 1 
Simple 1.40 1.16-1.68 1.36 1.13-1.64 
Moderate 1.38 1.07-1.79 1.37 1.01-1.78 
Complex 3.51 2.60-4.74 3.40 2.50-4.63 
*Adjusted for maternal age and calendar year at inclusion, parity, ethnicity, and level of education
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Table S7. Hazard ratio of SGA (SGA defines as falling below two standard deviations of the mean 
birth weight). 
Crude Adjusted* 
N events HR 95% CI Overall 
p-value 
N events HR 95% CI Overall 
p-value 
Small for gestational age 25,056 <0.001 24,182 <0.001 
No CHD 1.37 1.09-1.74 1.25 0.98-1.59 
Simple 1.67 1.20-2.31 1.63 1.17-2.27 
Moderate 3.81 2.52-5.75 3.72 2.46-5.64 
Complex 
*Adjusted for maternal age and calendar year at inclusion, parity, ethnicity, and level of education
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